42-1
42nd Parliament,
1st Session
(December 3, 2015 - September 11, 2019)
Select a different session
Meeting Detail
Study on prescription pharmaceuticals in Canada
Topic:
Witnesses
- Hugh MacLeod, Chief Executive Officer(Canadian Patient Safety Institute)
- Emily Musing, Board member(Canadian Patient Safety Institute)
- Dr. Ingrid Sketris, Councillor(Health Council of Canada)
Meeting with interpretation and transcription